HAO
Haoxi Health Technology Limited Class A Ordinary Shares
NASDAQ: HAO · COMMUNICATION SERVICES · ADVERTISING AGENCIES
$0.03
+1.65% today
Updated 2026-06-02
Market cap
$1.97M
P/E ratio
—
P/S ratio
0.05x
EPS (TTM)
$-16.60
Dividend yield
—
52W range
$1 – $218
Volume
47.0M
WallStSmart proprietary scores
49
out of 100
Grade: C
Sell
Investment rating
8.7
Growth
A9.0
Quality
A+2.0
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
5.8
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$1.63
+4624.64%
12-Month target
$1.63
+4624.64%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 5.80 — safe zone
+ Revenue growth 41.20% QoQ
+ Debt/equity 0.10x — low leverage
Risks
- Thin margins at -6.50%
- Negative free cash flow $-2.27M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $28.23M | $48.52M | $48.52M | $32.80M | $42.68M |
| Net income | $969752.00 | $1.29M | $1.29M | $3.88M | $-6.88M |
| EPS | — | — | — | — | $-16.60 |
| Free cash flow | $-917632.00 | $-802943.00 | $-802943.00 | $-3.36M | $-2.27M |
| Profit margin | 3.44% | 2.66% | 2.66% | 11.82% | -6.50% |
Peer comparison
Smart narrative
Haoxi Health Technology Limited Class A Ordinary Shares trades at $0.03. Our Smart Value Score of 49/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 5.80, it sits in the safe zone. TTM revenue stands at $42.68M. with profit margins at -6.50%.
Frequently asked questions
What is Haoxi Health Technology Limited Class A Ordinary Shares's stock price?
Haoxi Health Technology Limited Class A Ordinary Shares (HAO) trades at $0.03, on a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Haoxi Health Technology Limited Class A Ordinary Shares overvalued?
Haoxi Health Technology Limited Class A Ordinary Shares carries a Smart Value Score of 49/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Haoxi Health Technology Limited Class A Ordinary Shares (HAO)?
The 12-month analyst consensus target is $1.63, about 4624.6% above the current $0.03. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Haoxi Health Technology Limited Class A Ordinary Shares's revenue?
Haoxi Health Technology Limited Class A Ordinary Shares's trailing twelve-month revenue is $42.68M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Haoxi Health Technology Limited Class A Ordinary Shares's Altman Z-Score is 5.80, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorCOMMUNICATION SERVICES
IndustryADVERTISING AGENCIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.05x
ROE-15.51%
Beta-1.38
50D MA$86.81
200D MA$134.17
Shares out0.00B
Float0.00B
Short ratio—
Avg volume47.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—